Cargando…
RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial
BACKGROUND: With the aging population, the prevalence and incidence of cerebrovascular disease will continue to rise, as well as the number of individuals with vascular cognitive impairment/dementia (VCID). No specific FDA-approved treatments for VCID exist. Although clinical evidence supports that...
Autores principales: | Ahmed, Heba A., Ishrat, Tauheed, Pillai, Bindu, Fouda, Abdelrahman Y., Sayed, Mohammed A., Eldahshan, Wael, Waller, Jennifer L., Ergul, Adviye, Fagan, Susan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090822/ https://www.ncbi.nlm.nih.gov/pubmed/30103772 http://dx.doi.org/10.1186/s12974-018-1262-x |
Ejemplares similares
-
Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension
por: Alhusban, Ahmed, et al.
Publicado: (2017) -
Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats
por: Sayed, Mohammed A., et al.
Publicado: (2020) -
Erratum to: Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke
por: Alhusban, Ahmed, et al.
Publicado: (2016) -
Role of Matrix Metalloproteinase Activity in the Neurovascular Protective Effects of Angiotensin Antagonism
por: Ishrat, Tauheed, et al.
Publicado: (2014) -
Within the Brain: The Renin Angiotensin System
por: Jackson, LaDonya, et al.
Publicado: (2018)